Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience

Back

ESC Premium Access

Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience

Session: Stroke prevention in atrial fibrillation

Topic: Oral Anticoagulation

Speaker: Mr J. Komen (Utrecht, NL)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Mr Joris Komen

Institute for Pharmaceutical Sciences, Utrecht (Netherlands (The))

0 follower

3 more presentations in this session

Stroke prevention in atrial fibrillation - State of the art

Speaker: Professor J. Steffel (Zurich, CH)

Access

Slides

Video

Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

Speaker: Doctor M. Kerneis (Paris, FR)

LAA occlusion - Between belief and evidence

Speaker: Professor M. Glikson (Jerusalem, IL)

Access

Slides

Video

Access the full session

Stroke prevention in atrial fibrillation

Speakers: Mr J. Komen, Professor J. Steffel, Doctor M. Kerneis, Professor M. Glikson

Access

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience

About the speaker

Mr Joris Komen

3 more presentations in this session

Stroke prevention in atrial fibrillation - State of the art

Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

LAA occlusion - Between belief and evidence

Access the full session

Stroke prevention in atrial fibrillation

About the event

ESC Congress 2018

ESC 365 is supported by